Wedbush Reaffirms Outperform Rating for Tango Therapeutics (TNGX)

1 day ago 2

Tango Therapeutics Inc. (NASDAQ:TNGX) is 1 of the 10 astir shorted biotech stocks to bargain according to hedge funds.

On March 6, Wedbush accrued the firm’s terms people connected Tango Therapeutics Inc. (NASDAQ:TNGX) from $15 to $19 pursuing the company’s 4th fourth fiscal results and firm updates. The steadfast maintained an Outperform standing connected the shares, with a terms people indicating an upside of much than 12%.

Wedbush noted that vopimetostat, a macromolecule arginine methyltransferase 5 inhibitor, remains connected way to participate its archetypal pivotal survey successful 2026. The planned proceedings volition measure the therapy successful second-line pancreatic ductal adenocarcinoma.

Wedbush Reaffirms Outperform Rating for Tango Therapeutics (TNGX)

Wedbush Reaffirms Outperform Rating for Tango Therapeutics (TNGX)

On February 23, Mizuho initiated sum of Tango Therapeutics Inc. (NASDAQ:TNGX) with an Outperform standing and $19 terms target. The steadfast believes that the company’s pb precision oncology candidate, vopimetostat, has the imaginable for “first-in-class and best-in-class” opportunities arsenic monotherapy and successful operation with RAS(ON) inhibitors for pancreatic ductal adenocarcinoma and non-small compartment lung cancer.

Mizuho estimates that the institution could make $1.8 cardinal successful risk-adjusted worldwide income of vopimetostat by 2035. It besides anticipates affirmative Phase I information successful 2026, which volition effect successful “significant outperformance” of the shares.

Tango Therapeutics Inc. (NASDAQ:TNGX) is simply a precision oncology institution dedicated to uncovering targeted treatments for crab patients who presently person constricted options. Their pipeline zeroes successful connected circumstantial familial vulnerabilities successful tumors, with promising therapies successful objective trials targeting tough-to-treat cancers similar pancreatic cancer, lung cancer, and glioblastoma.

While we admit the imaginable of TNGX arsenic an investment, we judge definite AI stocks connection greater upside imaginable and transportation little downside risk. If you’re looking for an highly undervalued AI banal that besides stands to payment importantly from Trump-era tariffs and the onshoring trend, spot our escaped study connected the best short-term AI stock.

READ NEXT: 40 Most Popular Stocks Among Hedge Funds Heading Into 2026 and 12 Oversold Financial Stocks to Invest successful According to Hedge Funds.

Disclosure: None. Follow Insider Monkey connected Google News.

Read Entire Article